Pain
Conference Coverage
New studies expand on Aimovig for migraine
SAN FRANCISCO – “It’s a very encouraging 1-year study for erenumab,” said Stewart J. Tepper, MD.
Daily News Podcast
Is fibromyalgia one disorder – or two?
And breast cancer patients don’t get the financial counseling they want from their clinicians.
From the Journals
Fibromyalgia should be seen as one, not two disorders
Conference Coverage
Opioid crisis brings bonanza for headache research
From the Journals
Nearly one-quarter of presurgery patients already using opioids
Surgical patients should be asked about their opioid use and pain history.
Law & Medicine
Malpractice and pain management
From the Journals
Assessing adverse events tied to outpatient opioid use in children
Conference Coverage
Migraine treatment insights offered for noninvasive vagus nerve stimulation
News from the FDA/CDC
Fentanyl analogs nearly double their overdose death toll
From 2016 to 2017, carfentanil-related deaths were up 98%.
Conference Coverage
Device impresses for chronic cluster headache attacks
Conference Coverage
OnabotulinumtoxinA crushes topiramate in chronic migraine PRO benefits
SAN FRANCISCO – Investigator asks: How can onabotulinumtoxinA possibly still be considered a third- or fourth-line therapy?